{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:18:26Z","timestamp":1793449106537,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.ejca.2007.11.022","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T17:51:02Z","timestamp":1199296262000},"page":"545-550","source":"Crossref","is-referenced-by-count":156,"title":["Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience"],"prefix":"10.1016","volume":"44","author":[{"given":"Maretta","family":"De Ioris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Brugieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Maibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Shafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joszef","family":"Zsiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Czaudzerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Perilongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2007.11.022_bib1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/cncr.11585","article-title":"Where do we stand with hepatoblastoma? A review","volume":"98","author":"Schnater","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2007.11.022_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-3468(95)90762-9","article-title":"Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma \u2013 a report from the German Cooperative Pediatric Liver Tumor Study HB-89","volume":"30","author":"Von Schweinitz","year":"1995","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ejca.2007.11.022_bib3","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2000.18.22.3819","article-title":"Cisplatin, doxorubicin and delayed surgery for childhood hepatoblastoma: a successful approach \u2013 results of the first prospective study of the International Society of Paediatric Oncology","volume":"18","author":"Pritchard","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2007.11.022_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1470-2045(00)00018-8","article-title":"Liver Tumour Study Group of the International Society of Paediatric Oncology. SIOPEL trials using preoperative chemotherapy in hepatoblastoma","volume":"1","author":"Perilongo","year":"2000","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2007.11.022_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","article-title":"Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology \u2013 SIOPEL 2","volume":"40","author":"Perilongo","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2007.11.022_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P","article-title":"Prognostic factors and staging systems in childhood hepatoblastoma","volume":"74","author":"Von Schweinitz","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2007.11.022_bib7","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","article-title":"Pretreatment prognostic factors for children with hepatoblastoma \u2013 results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1","volume":"36","author":"Brown","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2007.11.022_bib8","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.1997.15.3.1190","article-title":"Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children\u2019s Cancer Group","volume":"15","author":"Van Tornout","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2007.11.022_bib9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ejca.2005.02.035","article-title":"The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis","volume":"41","author":"Zimmermann","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2007.11.022_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observation","volume":"53","author":"Kaplan","year":"1959","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ejca.2007.11.022_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cncr.10632","volume":"95","author":"Fuchs","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2007.11.022_bib12","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","article-title":"Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children\u2019s Cancer Group and the Pediatric Oncology Group","volume":"18","author":"Ortega","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2007.11.022_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1258\/000456306777695726","article-title":"The hook effect: a need for constant vigilance","volume":"43","author":"Jassam","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ejca.2007.11.022_bib14","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.ejca.2006.05.011","article-title":"Liver cancer in European children: incidence and survival, 1978\u20131997. Report from the Automated Childhood Cancer Information System project","volume":"42","author":"Stiller","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2007.11.022_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G","article-title":"Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma","volume":"64","author":"Haas","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2007.11.022_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/15513819209023293","article-title":"Hepatoblastoma: the prognostic significance of histologic type","volume":"12","author":"Conran","year":"1992","journal-title":"Pediatr Pathol"},{"key":"10.1016\/j.ejca.2007.11.022_bib17","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#","article-title":"Small cell undifferentiated histology in hepatoblastoma may be unfavorable","volume":"92","author":"Haas","year":"2001","journal-title":"Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804907009677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804907009677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T18:50:58Z","timestamp":1546368658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804907009677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0959804907009677"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2007.11.022","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}